In Vivo Clearance of an Intracellular Bacterium, Francisella Tularensis LVS, is Dependent on the P40 Subunit of Interleukin-12 (IL-12) but Not on IL-12 P70
Overview
Affiliations
To determine the role of interleukin-12 (IL-12) in primary and secondary immunity to a model intracellular bacterium, we have comprehensively evaluated infection with Francisella tularensis LVS in three murine models of IL-12 deficiency. Mice lacking the p40 protein of IL-12 (p40 knockout [KO] mice) and mice treated in vivo with neutralizing anti-IL-12 antibodies survived large doses of primary and secondary LVS infection but never cleared bacteria and exhibited a chronic infection. In dramatic contrast, mice lacking the p35 protein (p35 KO mice) of heterodimeric IL-12 readily survived large doses of primary sublethal LVS infection as well as maximal secondary lethal challenge, with only a slight delay in clearance of bacteria. LVS-immune wild-type (WT) lymphocytes produced large amounts of gamma interferon (IFN-gamma), but p35 KO and p40 KO lymphocytes produced much less; nonetheless, similar amounts of NO were found in all cultures containing immune lymphocytes, and all immune lymphocytes were equally capable of controlling intracellular growth of LVS in vitro. Purified CD4(+) and CD8(+) T cells from both WT and p40 KO mice controlled intracellular growth, even though T cells from WT mice produced much more IFN-gamma than those from p40 KO mice, and p40 KO T cells did not adopt a Th2 phenotype. Thus, while IL-12 p70 stimulation of IFN-gamma production may be important for bacteriostasis, IL-12 p70 is not necessary for appropriate development of LVS-immune T cells that are capable of controlling intracellular bacterial growth and for clearance of primary or secondary LVS infection. Instead, an additional mechanism dependent on the IL-12 p40 protein, either alone or in another complex such as the newly discovered heterodimer IL-23, appears to be responsible for actual clearance of this intracellular bacterium.
Hartman S, Weiss M, Temple H, Donnelly B, Pasula R, Poling H J Interferon Cytokine Res. 2023; 43(9):427-434.
PMID: 37725010 PMC: 10517325. DOI: 10.1089/jir.2023.0046.
Mittereder L, Swoboda J, De Pascalis R, Elkins K PLoS One. 2023; 18(3):e0283161.
PMID: 36972230 PMC: 10042368. DOI: 10.1371/journal.pone.0283161.
Wang H, Nelson A, Wang B, Zhao Z, Lim X, Shi M Immunol Cell Biol. 2022; 100(7):547-561.
PMID: 35514192 PMC: 9539875. DOI: 10.1111/imcb.12556.
Hoang K, Fitch J, White P, Mohapatra N, Gunn J J Bacteriol. 2020; 202(21).
PMID: 32839173 PMC: 7549357. DOI: 10.1128/JB.00321-20.
The Immunobiology of the Interleukin-12 Family: Room for Discovery.
Tait Wojno E, Hunter C, Stumhofer J Immunity. 2019; 50(4):851-870.
PMID: 30995503 PMC: 6472917. DOI: 10.1016/j.immuni.2019.03.011.